Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.

Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DH, Gregson J, Sawyer AW, Hamers RL, Ndembi N, Pillay D, Bertagnolio S.

Lancet. 2012 Oct 6;380(9849):1250-8. doi: 10.1016/S0140-6736(12)61038-1. Epub 2012 Jul 23. Erratum in: Lancet. 2012 Oct 6;380(9849):1230.

2.

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.

Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KC, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vugt M, de Wit TF; PharmAccess African Studies to Evaluate Resistance (PASER)..

Lancet Infect Dis. 2011 Oct;11(10):750-9. doi: 10.1016/S1473-3099(11)70149-9. Epub 2011 Jul 27.

PMID:
21802367
3.

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CA, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HM, van de Vijver DA, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JP, Vandamme AM, Shafer RW.

PLoS Med. 2015 Apr 7;12(4):e1001810. doi: 10.1371/journal.pmed.1001810. eCollection 2015 Apr. Erratum in: PLoS Med. 2015 Jun;12(6):e1001845.

5.

Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world.

Frentz D, Boucher CA, van de Vijver DA.

AIDS Rev. 2012 Jan-Mar;14(1):17-27. Review.

PMID:
22297501
6.

One world, one hope: the cost of providing antiretroviral therapy to all nations.

Hogg RS, Weber AE, Craib KJ, Anis AH, O'Shaughnessy MV, Schechter MT, Montaner JS.

AIDS. 1998 Nov 12;12(16):2203-9.

PMID:
9833862
7.

Antiretroviral (ARV) drug resistance in the developing world.

Shekelle P, Maglione M, Geotz MB, Wagner G, Wang Z, Hilton L, Carter J, Chen S, Tringle C, Mojica W, Newberry S.

Evid Rep Technol Assess (Full Rep). 2007 Sep;(156):1-74. Review.

8.

Update on HIV-1 acquired and transmitted drug resistance in Africa.

Ssemwanga D, Lihana RW, Ugoji C, Abimiku A, Nkengasong J, Dakum P, Ndembi N.

AIDS Rev. 2015 Jan-Mar;17(1):3-20. Review.

PMID:
25427100
9.

HIV-1 transmitted drug resistance in Latin America and the Caribbean: what do we know?

Pineda-Peña AC, Bello DC, Sussmann O, Vandamme AM, Vercauteren J, van Laethem K, Gómez-López A.

AIDS Rev. 2012 Oct-Dec;14(4):256-67. Review.

PMID:
23258300
10.

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.

Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, Myers B, Ambekar A, Strathdee SA; 2009 Reference Group to the UN on HIV and Injecting Drug Use..

Lancet. 2010 Mar 20;375(9719):1014-28. doi: 10.1016/S0140-6736(10)60232-2. Epub 2010 Feb 26. Review.

PMID:
20189638
11.

Meta-analysis and time series modeling allow a systematic review of primary HIV-1 drug-resistant prevalence in Latin America and Caribbean.

Coelho AV, De Moura RR, Da Silva RC, Kamada AJ, Guimarães RL, Brandão LA, Coelho HF, Crovella S.

Curr HIV Res. 2015;13(2):125-42. Review.

PMID:
25777517
12.

Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India.

Neogi U, Gupta S, Palchaudhuri R, Rao SD, Shastri S, Diwan V, Laishram RS, De Costa A, Shet A.

Antivir Ther. 2014;19(8):813-8. doi: 10.3851/IMP2769. Epub 2014 Apr 4.

PMID:
24699043
13.

The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models.

Blower S, Bodine E, Kahn J, McFarland W.

AIDS. 2005 Jan 3;19(1):1-14. Review.

PMID:
15627028
14.

HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.

Sigaloff KC, Calis JC, Geelen SP, van Vugt M, de Wit TF.

Lancet Infect Dis. 2011 Oct;11(10):769-79. doi: 10.1016/S1473-3099(11)70141-4. Epub 2011 Aug 25. Review.

PMID:
21872531
15.

Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review.

Stadeli KM, Richman DD.

Antivir Ther. 2013;18(1):115-23. doi: 10.3851/IMP2437. Epub 2012 Oct 10. Review.

16.

Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation.

Cambiano V, Bertagnolio S, Jordan MR, Pillay D, Perriëns JH, Venter F, Lundgren J, Phillips A.

AIDS. 2014 Jan;28 Suppl 1:S15-23. doi: 10.1097/QAD.0000000000000082.

PMID:
24468943
17.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
18.

Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa.

Hamers RL, Sigaloff KC, Kityo C, Mugyenyi P, de Wit TF.

Curr Opin HIV AIDS. 2013 Jan;8(1):19-26. doi: 10.1097/COH.0b013e32835b7f94. Review.

PMID:
23143140
19.

Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.

ART-LINC Collaboration of International Databases to Evaluate AIDS (IeDEA)., Keiser O, Anastos K, Schechter M, Balestre E, Myer L, Boulle A, Bangsberg D, Touré H, Braitstein P, Sprinz E, Nash D, Hosseinipour M, Dabis F, May M, Brinkhof MW, Egger M.

Trop Med Int Health. 2008 Jul;13(7):870-9. doi: 10.1111/j.1365-3156.2008.02078.x. Epub 2008 Mar 27.

20.

Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004.

Pillay V, Ledwaba J, Hunt G, Rakgotho M, Singh B, Makubalo L, Bennett DE, Puren A, Morris L.

Antivir Ther. 2008;13 Suppl 2:101-7.

PMID:
18575198

Supplemental Content

Support Center